NCT03526224View on ClinicalTrials.gov

Teriflunomide Tecfidera LMCE

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

June 14, 2018

Primary Completion Date

July 10, 2019

Study Completion Date

July 10, 2019

Conditions
TecfideraTeriflunomide
Interventions
DRUG

Dimethyl Fumarate

Individuals with MS treated with dimethyl fumarate (Tecfidera)

DRUG

Teriflunomide

Individuals with MS treated with teriflunomide (Aubagio)

Trial Locations (1)

14203

Buffalo Neuroimaging Analysis Center, Buffalo

All Listed Sponsors
lead

University at Buffalo

OTHER

NCT03526224 - Teriflunomide Tecfidera LMCE | Biotech Hunter | Biotech Hunter